Dexcom

company that develops, manufactures and distributes continuous glucose monitoring systems

DXCM Nasdaq ISIN US2521311074 SEC CIK 1093557 LEI 549300YSK3QDSFR5EU59
Follow Dexcom Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.3B +11.2% vs same quarter last year
Net income $275.1M −3.1% vs same quarter last year
EPS, diluted $0.72 +2.9% vs same quarter last year
Operating cash flow $325.6M −50.7% vs same quarter last year
Revenue by quarter
$1.1B
$1B
$1.2B
$1.2B
$1.3B
$1.2B
$1.3B
$1.3B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$2B$0$2B$4B$6BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$4.7B$836.3M
FY24$4B$576.2M
FY23$3.6B$541.5M
FY22$2.9B$341.2M
FY21$2.4B$216.9M
FY20$1.9B$549.7M
FY19$1.5B$101.1M
FY18$1B−$127.1M
FY17$718.5M−$50.2M
FY16$573.3M−$65.6M
FY15$402M−$57.6M
FY14$259.2M−$22.4M
FY13$160M−$29.8M
FY12$99.9M−$54.5M
FY11$76.3M−$44.7M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2560.1%19.6%17.9%
FY2460.5%14.9%14.3%
FY2363.2%16.5%14.9%
FY2264.7%13.4%11.7%
FY2168.6%10.9%8.9%
FY2066.4%15.5%28.5%
FY1963.1%9.6%6.8%
FY1864.4%−18.1%−12.3%
FY1768.5%−5.9%−7%
FY1666%−11.1%−11.4%
FY1569.3%−14.2%−14.3%
FY1468%−8.3%−8.6%
FY1362.6%−18.1%−18.6%
FY1246.6%−55.8%−54.6%
FY1147.1%−58.7%−58.6%
Free cash flowOperating cash flow minus capital expenditure
−$500M$0$500M$1B$1.5BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.1B
FY24$630.7M
FY23$511.9M
FY22$304.7M
FY21$53.3M
FY20$276.6M
FY19$134.5M
FY18$56.1M
FY17$26M
FY16$500K
FY15$15.7M
FY14$7.4M
FY13−$5.5M
FY12−$42.6M
FY11−$38.1M
Returned to shareholdersDividends paid and shares bought back
$0$200M$400M$600M$800MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$500M
FY24$750M
FY23$688.7M
FY22$557.7M
FY21$0
FY20$0
FY19$0
FY18$100M
FY17$0
FY16$0
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Dexcom
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDexcomHealthcare median
FY2517.9%−30.6%
FY2414.3%−47%
FY2314.9%−58%
FY2211.7%−80.4%
FY218.9%−71.9%
FY2028.5%−62.2%
FY196.8%−46.3%
FY18−12.3%−49.6%
FY17−7%−45.9%
FY16−11.4%−36%
FY15−14.3%−38.4%
FY14−8.6%−35.5%
FY13−18.6%−37.1%
FY12−54.6%−29.1%
FY11−58.6%−27.9%